-
Mashup Score: 17Integrating cilta-cel into earlier lines of therapy: Rationale and latest data from CARTITUDE-2 and CARTITUDE-4 - 2 month(s) ago
Here we summarize the rationale and latest clinical trial data investigating the use of cilta-cel in earlier lines of therapy in multiple myeloma.
Source: multiplemyelomahub.comCategories: General Medicine News, Onc News and JournalsTweet
Could cilta-cel be successfully implemented into earlier lines of therapy in #MultipleMyeloma? Read more here for the rationale for incorporating cilta-cel in lines 1–3 and the latest data from CARTITUDE-2 and CARTITUDE-4 👉 https://t.co/ffp4UYCGH2 #mmsm #myeloma #CAR-T #RRMM https://t.co/cRYFbDwhGH